1. Home
  2. GH vs UFPI Comparison

GH vs UFPI Comparison

Compare GH & UFPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GH
  • UFPI
  • Stock Information
  • Founded
  • GH 2011
  • UFPI 1955
  • Country
  • GH United States
  • UFPI United States
  • Employees
  • GH N/A
  • UFPI N/A
  • Industry
  • GH Medical Specialities
  • UFPI Forest Products
  • Sector
  • GH Health Care
  • UFPI Basic Materials
  • Exchange
  • GH Nasdaq
  • UFPI Nasdaq
  • Market Cap
  • GH 4.9B
  • UFPI 5.8B
  • IPO Year
  • GH 2018
  • UFPI 1993
  • Fundamental
  • Price
  • GH $47.81
  • UFPI $101.81
  • Analyst Decision
  • GH Strong Buy
  • UFPI Strong Buy
  • Analyst Count
  • GH 20
  • UFPI 4
  • Target Price
  • GH $54.35
  • UFPI $143.00
  • AVG Volume (30 Days)
  • GH 1.9M
  • UFPI 534.6K
  • Earning Date
  • GH 07-30-2025
  • UFPI 07-29-2025
  • Dividend Yield
  • GH N/A
  • UFPI 1.38%
  • EPS Growth
  • GH N/A
  • UFPI N/A
  • EPS
  • GH N/A
  • UFPI 6.11
  • Revenue
  • GH $773,996,000.00
  • UFPI $6,608,862,000.00
  • Revenue This Year
  • GH $23.37
  • UFPI $0.88
  • Revenue Next Year
  • GH $21.31
  • UFPI $4.65
  • P/E Ratio
  • GH N/A
  • UFPI $16.64
  • Revenue Growth
  • GH 28.20
  • UFPI N/A
  • 52 Week Low
  • GH $20.14
  • UFPI $93.00
  • 52 Week High
  • GH $53.42
  • UFPI $141.33
  • Technical
  • Relative Strength Index (RSI)
  • GH 45.10
  • UFPI 49.40
  • Support Level
  • GH $48.90
  • UFPI $102.17
  • Resistance Level
  • GH $52.46
  • UFPI $109.80
  • Average True Range (ATR)
  • GH 1.98
  • UFPI 3.85
  • MACD
  • GH -0.55
  • UFPI -0.11
  • Stochastic Oscillator
  • GH 8.33
  • UFPI 52.44

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About UFPI UFP Industries Inc.

UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate.

Share on Social Networks: